Company Filing History:
Years Active: 2016-2018
Title: The Innovative Contributions of Christopher J Lengner
Introduction
Christopher J Lengner is a prominent inventor based in Wellesley, MA (US). He has made significant contributions to the field of biomedical research, particularly in the area of cell reprogramming. With a total of three patents to his name, Lengner's work has the potential to impact regenerative medicine and therapeutic applications.
Latest Patents
One of Lengner's latest patents focuses on the reprogramming of somatic cells. The disclosure relates to a method of reprogramming one or more somatic cells, such as partially differentiated or fully/terminally differentiated somatic cells, to a less differentiated state, like a pluripotent or multipotent state. In further embodiments, the invention also relates to reprogrammed somatic cells produced by methods of the invention, their uses, and methods for identifying agents useful for reprogramming somatic cells.
Career Highlights
Christopher J Lengner is affiliated with the Whitehead Institute for Biomedical Research, where he conducts his research. His innovative approaches and findings have garnered attention in the scientific community, contributing to advancements in understanding cellular differentiation and reprogramming.
Collaborations
Lengner has collaborated with notable scientists in his field, including Rudolf Jaenisch and Yaqub Hanna. These collaborations have further enriched his research and expanded the impact of his work.
Conclusion
Christopher J Lengner's contributions to the field of biomedical research, particularly in cell reprogramming, highlight his role as an influential inventor. His patents and collaborations continue to pave the way for advancements in regenerative medicine.